首页|The CRIPSR/Cas gene-editing system-an immature but useful toolkit for experimental and clinical medicine

The CRIPSR/Cas gene-editing system-an immature but useful toolkit for experimental and clinical medicine

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
A Chinese scientist,Jiankui He,and his creation of the world's first genetically altered baby made headlines recently.As a newly developed gene-editing technique,the CRISPR/Cas system should not be applied to human beings for reproductive purposes until it has been extensively tested.However,numerous experimental research studies in human somatic,germline cells,and even in embryos,have been conducted,which have shown CRISPR/Cas to be a useful tool for human genome editing and a potential therapeutic method for future clinical use.

CRISPR-Casgene editinggene therapyhuman embryosrecombinant DNA

Yuyan Yang、Yue Huang

展开 >

State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing, China

Department of Medical Genetics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

National Key Research and Development Program of ChinaCAMS Innovation Fund for Medical Sciences

Grant/Award Number:2016YFA0100103Grant/Award Number:2016-I2M-3-002

2019

动物模型与实验医学(英文)
中国实验动物学会,中国医学科学院医学实验动物研究所

动物模型与实验医学(英文)

CSCD
ISSN：2096-5451
年,卷(期)：2019.2(1)
  • 1
  • 41